AtriCure announces stock offering

The company said it plans to use the net proceeds from the offering for general corporate purposes and working capital.

AtriCure announced the pricing of the public offering of 3,475,000 shares of common stock at a price of $7.25 per share.

AtriCure has also granted the underwriter a 30-day option to purchase up to an additional 521,250 shares of common stock to cover over-allotments, if any. Piper Jaffray & Co. is acting as the sole manager for the offering.

Net proceeds from the sale of the shares are expected to be approximately $23.5 million. The offering is subject to customary closing conditions and is expected to close on Tuesday.

Earlier this month, the company said preliminary revenue for the fourth quarter of 2012 is expected to be approximately $18.4 million, 9.5 percent more than the fourth quarter of 2011. Preliminary revenue for full year 2012 is expected to be $70.2 million, reflecting year-over-year growth of 9.1 percent from 2011.

Thank you for reading the Springfield News-Sun and for supporting local journalism. Subscribers: log in for access to your daily ePaper and premium newsletters.

Thank you for supporting in-depth local journalism with your subscription to the Springfield News-Sun. Get more news when you want it with email newsletters just for subscribers. Sign up here.